GlassScriptPhysician profile
Vasti L Broadstone
NPI 1760420137
$7,969.40
in general payments reported to CMS, 2019-2025
48 companies · $1,671 in 2025
The $1,671 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,634 · 2020: $356 · 2021: $749 · 2022: $1,209 · 2023: $1,059 · 2024: $1,290 · 2025: $1,671.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,800 · Consulting Fee: $175 · Education: $45.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,799.72 |
| Consulting Fee | $175.00 |
| Education | $45.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $914.57 | 2019-2025 | Freestyle Libre 3, Freestyle Libre |
| Novo Nordisk INC | $709.80 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $615.72 | 2019-2025 | Evenity, Prolia, Prolia |
| Lilly USA, LLC | $613.64 | 2019-2025 | Mounjaro, Zepbound, Humulin |
| Sanofi-Aventis U.S. LLC | $482.03 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $447.81 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Medtronic, INC. | $373.39 | 2022-2025 | Minimed 780g, Intellis Adaptivestim |
| Insulet Corporation | $358.02 | 2019-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $305.40 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $301.30 | 2019-2020 | |
| Amarin Pharma, INC. | $251.05 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $204.22 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Ascendis Pharma Endocrinology INC | $186.62 | 2025 | Yorvipath |
| Alexion Pharmaceuticals, INC. | $176.41 | 2022-2025 | Strensiq |
| Novartis Pharmaceuticals Corporation | $159.28 | 2022-2024 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $148.47 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $143.44 | 2019-2022 | |
| Shire North American Group INC | $129.36 | 2019 | |
| Radius Health, INC. | $125.99 | 2022-2024 | Tymlos |
| Esperion Therapeutics, INC. | $124.97 | 2022 | |
| Amryt Pharma Holdings LTD | $118.02 | 2020-2022 | |
| Abbvie INC. | $114.81 | 2021-2024 | Synthroid |
| Dexcom, INC. | $113.31 | 2019-2023 | Dexcom G6 Transmitter |
| Corcept Therapeutics | $100.96 | 2019-2023 | Korlym |
| Tandem Diabetes Care, INC. | $76.77 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Merck Sharp & Dohme LLC | $70.99 | 2020-2022 | |
| Mannkind Corporation | $63.60 | 2021-2023 | Afrezza |
| Ultragenyx Pharmaceutical INC. | $56.53 | 2019-2022 | |
| Medtronic Minimed, INC. | $53.08 | 2019-2020 | |
| Averitas Pharma INC. | $48.96 | 2024 | Qutenza |
| Recordati_rare_diseases_inc. | $37.78 | 2025 | Isturisa |
| Kowa Pharmaceuticals America, INC. | $31.06 | 2020-2021 | |
| Beta Bionics, INC. | $30.57 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Zealand Pharma US, INC. | $27.89 | 2021-2022 | |
| Amneal Pharmaceuticals LLC | $25.41 | 2020-2021 | |
| Nevro Corp. | $22.26 | 2024 | Senza |
| Soleno Therapeutics, INC. | $21.77 | 2025 | Vykat Xr |
| Verity Pharmaceuticals INC. | $20.25 | 2025 | Tlando |
| Grt US Holding, INC. | $19.22 | 2021 | |
| Chiesi USA, INC. | $19.15 | 2024 | Mycapssa |
| Becton, Dickinson and Company | $18.78 | 2021 | |
| Senseonics, Incorporated | $17.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.26 | 2019 | |
| Ibsa Pharma INC. | $15.85 | 2019 | |
| Madrigal Pharmaceuticals | $15.28 | 2025 | Rezdiffra |
| Horizon Therapeutics Plc | $15.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.11 | 2019 | |
| Lifescan, INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vasti Broadstone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.